We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Adtalem & CDEMA Unite to Boost Caribbean's Disaster Issues
Read MoreHide Full Article
Caribbean Center for Disaster Medicine (“CCDM”), a unit of Adtalem Global Education’s (ATGE - Free Report) American University of the Caribbean School of Medicine, has partnered with Caribbean Disaster Emergency Management Agency (“CDEMA”) to enhance the region’s disaster-related medicine education and training.
With this collaboration CDEMA and CCDM will put together stakeholders as well as resources to train professionals and enable the public to prepare for disaster-related medical and healthcare issues.
It will provide educational pathway program for safeguarding as well as promoting the overall health of people of Sint Maarten before, during and after a disaster.
Health Care & International Institutions’ Performance Bodes Well
American University of the Caribbean (“AUC”) School of Medicine — one of the medical and veterinary schools of Adtalem — provides training to physicians. The institute’s service is enhanced by international learning experiences, a diverse learning community as well as emphasis on social accountability and engagement.
AUC’s collaborative learning environment features multitude student organizations, small class sizes, international training opportunities and a team-based learning culture. This enables doctors to be part of a team that delivers empathetic, extraordinary care to a diverse patient population.
Notably, Adtalem’s health care and international institutions have shown significant improvement in revenues and profitability since fiscal 2013. The company’s fiscal 2019 revenues increased primarily on higher contribution from the Medical and Healthcare as well as Financial Services segments. In the first quarter of fiscal 2020, revenues in the segment rose 2.7% from the year-ago quarter’s figure. Precisely, Medical and Veterinary schools’ revenues rose 2.9% year over year in the fiscal first quarter.
Price Performance
Shares of Adtalem have declined 26% so far this year against the industry’s 38.9% growth. The company has been recording lower profits in the past few quarters due to certain restructuring charges related to the closing of the Ross University School of Medicine campus in Dominica. Also, real estate consolidations and increased marketing-related expenses are other factors that led to the downside.
Nevertheless, collaborations and strategic initiatives undertaken are expected to drive growth and enable the company regain momentum. Notably, Adtalem expects to generate revenue growth in the range of 5-7% in the fiscal 2020.
Zacks Rank & Key Picks
Currently, Adtalem carries a Zacks Rank #5 (Strong Sell).
Career Education’s earnings surpassed estimates in all of the trailing four quarters, the average being 23.9%.
New Oriental’s current-year earnings are expected to rise approximately 33.3%.
JAKKS Pacific has three-five year expected earnings per share growth rate of 5%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Adtalem & CDEMA Unite to Boost Caribbean's Disaster Issues
Caribbean Center for Disaster Medicine (“CCDM”), a unit of Adtalem Global Education’s (ATGE - Free Report) American University of the Caribbean School of Medicine, has partnered with Caribbean Disaster Emergency Management Agency (“CDEMA”) to enhance the region’s disaster-related medicine education and training.
With this collaboration CDEMA and CCDM will put together stakeholders as well as resources to train professionals and enable the public to prepare for disaster-related medical and healthcare issues.
It will provide educational pathway program for safeguarding as well as promoting the overall health of people of Sint Maarten before, during and after a disaster.
Health Care & International Institutions’ Performance Bodes Well
American University of the Caribbean (“AUC”) School of Medicine — one of the medical and veterinary schools of Adtalem — provides training to physicians. The institute’s service is enhanced by international learning experiences, a diverse learning community as well as emphasis on social accountability and engagement.
AUC’s collaborative learning environment features multitude student organizations, small class sizes, international training opportunities and a team-based learning culture. This enables doctors to be part of a team that delivers empathetic, extraordinary care to a diverse patient population.
Notably, Adtalem’s health care and international institutions have shown significant improvement in revenues and profitability since fiscal 2013. The company’s fiscal 2019 revenues increased primarily on higher contribution from the Medical and Healthcare as well as Financial Services segments. In the first quarter of fiscal 2020, revenues in the segment rose 2.7% from the year-ago quarter’s figure. Precisely, Medical and Veterinary schools’ revenues rose 2.9% year over year in the fiscal first quarter.
Price Performance
Shares of Adtalem have declined 26% so far this year against the industry’s 38.9% growth. The company has been recording lower profits in the past few quarters due to certain restructuring charges related to the closing of the Ross University School of Medicine campus in Dominica. Also, real estate consolidations and increased marketing-related expenses are other factors that led to the downside.
Nevertheless, collaborations and strategic initiatives undertaken are expected to drive growth and enable the company regain momentum. Notably, Adtalem expects to generate revenue growth in the range of 5-7% in the fiscal 2020.
Zacks Rank & Key Picks
Currently, Adtalem carries a Zacks Rank #5 (Strong Sell).
Some better-ranked stocks in the Zacks Consumer Discretionary sector are Career Education Corporation (CECO - Free Report) , New Oriental Education & Technology Group Inc (EDU - Free Report) and JAKKS Pacific, Inc (JAKK - Free Report) , each sporting a Zack Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Career Education’s earnings surpassed estimates in all of the trailing four quarters, the average being 23.9%.
New Oriental’s current-year earnings are expected to rise approximately 33.3%.
JAKKS Pacific has three-five year expected earnings per share growth rate of 5%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>